Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Effect of obesity intervention programs on adipokines, insulin resistance, lipid profile, and low-grade inflammation in 3- to 5-y-old children.

Bocca G, Corpeleijn E, Stolk RP, Wolffenbuttel BH, Sauer PJ.

Pediatr Res. 2014 Feb;75(2):352-7. doi: 10.1038/pr.2013.216. Epub 2013 Nov 14.

PMID:
24232638
2.

[TNF-alpha and carbohydrate and lipid parameters in overweight and obese children].

Goral J.

Ann Acad Med Stetin. 2008;54(2):14-21. Polish.

PMID:
19374226
3.

Circulating visfatin in obese non-diabetic patients in relation to cardiovascular risk factors, insulin resistance, and adipocytokines: a contradictory piece of the puzzle.

de Luis DA, Sagrado MG, Aller R, Conde R, Izaola O.

Nutrition. 2010 Nov-Dec;26(11-12):1130-3. doi: 10.1016/j.nut.2008.11.019. Epub 2009 Feb 10.

PMID:
19211226
4.

The relationship between serum adiponectin, tumor necrosis factor-alpha, leptin levels and insulin sensitivity in childhood and adolescent obesity: adiponectin is a marker of metabolic syndrome.

Alikaşifoğlu A, Gönç N, Özön ZA, Sen Y, Kandemir N.

J Clin Res Pediatr Endocrinol. 2009;1(5):233-9. doi: 10.4274/jcrpe.v1i5.233. Epub 2009 Aug 4.

5.

[Impact of weight loss on adipocytokines, C-reactive protein and insulin sensitivity in hypertensive women with central obesity].

Borges RL, Ribeiro-Filho FF, Carvalho KM, Zanella MT.

Arq Bras Cardiol. 2007 Dec;89(6):409-14. English, Portuguese.

6.

Metabolic syndrome, adipokines and ghrelin in overweight and obese schoolchildren: results of a 1-year lifestyle intervention programme.

Pedrosa C, Oliveira BM, Albuquerque I, Simões-Pereira C, Vaz-de-Almeida MD, Correia F.

Eur J Pediatr. 2011 Apr;170(4):483-92. doi: 10.1007/s00431-010-1316-2. Epub 2010 Oct 19.

PMID:
20957391
7.

Results of a multidisciplinary treatment program in 3-year-old to 5-year-old overweight or obese children: a randomized controlled clinical trial.

Bocca G, Corpeleijn E, Stolk RP, Sauer PJ.

Arch Pediatr Adolesc Med. 2012 Dec;166(12):1109-15. doi: 10.1001/archpediatrics.2012.1638.

PMID:
23108941
8.

[Plasma levels of adiponectin and tumor necrosis factor-alpha in children with obesity].

Yan WJ, Wu J, Mo J, Huang CW, Peng LW, Xu L.

Zhongguo Dang Dai Er Ke Za Zhi. 2009 Jan;11(1):47-50. Chinese.

PMID:
19149923
9.

Obesity and body fat classification in the metabolic syndrome: impact on cardiometabolic risk metabotype.

Phillips CM, Tierney AC, Perez-Martinez P, Defoort C, Blaak EE, Gjelstad IM, Lopez-Miranda J, Kiec-Klimczak M, Malczewska-Malec M, Drevon CA, Hall W, Lovegrove JA, Karlstrom B, Risérus U, Roche HM.

Obesity (Silver Spring). 2013 Jan;21(1):E154-61. doi: 10.1002/oby.20263.

10.

Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial.

Belenchia AM, Tosh AK, Hillman LS, Peterson CA.

Am J Clin Nutr. 2013 Apr;97(4):774-81. doi: 10.3945/ajcn.112.050013. Epub 2013 Feb 13.

11.

The association of cysteine with obesity, inflammatory cytokines and insulin resistance in Hispanic children and adolescents.

Elshorbagy AK, Valdivia-Garcia M, Refsum H, Butte N.

PLoS One. 2012;7(9):e44166. doi: 10.1371/journal.pone.0044166. Epub 2012 Sep 11.

12.
13.

Preliminary comparative study on the effect of different chinese drugs for strengthening Pi in antagonizing diet induced obesity.

Li X, Jiang P, Fu CG.

Chin J Integr Med. 2010 Apr;16(2):138-44. doi: 10.1007/s11655-010-0138-4. Epub 2010 May 16.

PMID:
20473739
14.

Plasma leptin is associated with insulin resistance independent of age, body mass index, fat mass, lipids, and pubertal development in nondiabetic adolescents.

Huang KC, Lin RC, Kormas N, Lee LT, Chen CY, Gill TP, Caterson ID.

Int J Obes Relat Metab Disord. 2004 Apr;28(4):470-5.

PMID:
14993909
15.

Variation of inflammatory parameters after sibutramine treatment compared to placebo in type 2 diabetic patients.

Derosa G, Maffioli P, Ferrari I, Palumbo I, Randazzo S, D'Angelo A, Cicero AF.

J Clin Pharm Ther. 2011 Oct;36(5):592-601. doi: 10.1111/j.1365-2710.2010.01217.x. Epub 2010 Nov 12.

PMID:
21070297
16.

Low-grade inflammation in overweight and obese adults is affected by weight loss program.

Petelin A, Bizjak M, Černelič-Bizjak M, Jurdana M, Jakus T, Jenko-Pražnikar Z.

J Endocrinol Invest. 2014 Aug;37(8):745-55. doi: 10.1007/s40618-014-0102-9. Epub 2014 Jun 10.

PMID:
24913237
17.

Association of circulating visfatin concentrations with insulin resistance and low-grade inflammation after dietary energy restriction in Spanish obese non-diabetic women: role of body composition changes.

Agueda M, Lasa A, Simon E, Ares R, Larrarte E, Labayen I.

Nutr Metab Cardiovasc Dis. 2012 Mar;22(3):208-14. doi: 10.1016/j.numecd.2010.06.010. Epub 2010 Oct 14.

PMID:
20951014
18.

Serum sphingolipids and inflammatory mediators in adolescents at risk for metabolic syndrome.

Majumdar I, Mastrandrea LD.

Endocrine. 2012 Jun;41(3):442-9. doi: 10.1007/s12020-011-9589-4. Epub 2012 Jan 7.

PMID:
22228496
19.

Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease.

Klein S, Fontana L, Young VL, Coggan AR, Kilo C, Patterson BW, Mohammed BS.

N Engl J Med. 2004 Jun 17;350(25):2549-57.

20.

Effects of 90-day hypolipidemic treatment on insulin resistance, adipokines and proinflammatory cytokines in patients with mixed hyperlipidemia and impaired fasting glucose.

Buldak L, Dulawa-Buldak A, Labuzek K, Okopien B.

Int J Clin Pharmacol Ther. 2012 Nov;50(11):805-13. doi: 10.5414/CP201735.

PMID:
22943927

Supplemental Content

Support Center